CSIMarket
 
Altamira Therapeutics Ltd   (CYTO)
Other Ticker:  
 
 
Price: $2.4200 $0.07 2.979%
Day's High: $2.4499 Week Perf: 43.2 %
Day's Low: $ 2.17 30 Day Perf: 31.52 %
Volume (M): 1,080 52 Wk High: $ 52.00
Volume (M$): $ 2,613 52 Wk Avg: $8.56
Open: $2.40 52 Wk Low: $0.39



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 0

Altamira Therapeutics Ltd
Altamira Therapeutics Ltd is a biotechnology company focused on the development and commercialization of innovative therapies for neurodegenerative diseases. The company's primary focus is on Parkinson's disease and other related movement disorders. Altamira Therapeutics aims to provide patients with effective treatments that alleviate their symptoms and improve their quality of life. The company utilizes advanced technologies and scientific expertise to discover and develop novel therapies that target the underlying causes of neurodegenerative diseases. Altamira Therapeutics is committed to making a meaningful impact in the field of neurology and improving the lives of patients suffering from these debilitating conditions.


   Company Address: Clarendon House Hamilton 0
   Company Phone Number: 295 59 50   Stock Exchange / Ticker: NASDAQ CYTO
   CYTO is expected to report next financial results on May 15, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

Altamira Therapeutics and Univercells Group Collaborate to Uphold mRNA Vaccine Delivery

Published Mon, Mar 25 2024 12:47 PM UTC

Altamira Therapeutics Joins Forces with Univercells Group to Advance Nanoparticle-Delivered mRNA VaccinesHAMILTON, BERMUDA, March 25, 2024 - Altamira Therapeutics Ltd. (Altamira) (Nasdaq:CYTO), a leading provider of nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, has announced a promising collaboration with Univercells Group (Univercells). T...






 

Altamira Therapeutics Ltd's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com